Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2020-09-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
独立董事候选人声明
Regulatory Filings Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, stating compliance with various legal and regulatory requirements for serving as an independent director. It includes personal affirmations about qualifications, independence, and adherence to relevant laws and stock exchange rules. There is no financial data, no report of financial performance, no voting results, no management changes, no earnings information, or any other typical financial or corporate event disclosures. This type of document is a regulatory compliance statement related to corporate governance but does not fit into categories like Annual Report, Management Information, or Proxy Solicitation. It is best classified under Regulatory Filings (RNS) as a compliance declaration that does not fit other specific categories.
2020-09-29 Chinese
独立董事提名人声明
Board/Management Information Classification · 100% confidence The document is a public statement from the board of directors nominating an independent director candidate for the company's board. It contains detailed declarations about the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There is no financial data, no discussion of financial results, no mention of annual or interim reports, earnings, or other financial filings. The content is focused on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is sufficient and the content is substantive, not merely an announcement or certification, so it is not RNS or RPA.
2020-09-29 Chinese
独立董事候选人声明
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for serving as an independent director. It includes statements about qualifications, independence, and adherence to relevant laws and stock exchange rules. There is no financial data, no report of financial performance, no voting results, no management changes, no earnings information, or other typical financial or corporate event disclosures. This type of document is related to board/management information, specifically concerning the appointment or status of a board member. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length and content support this classification with high confidence.
2020-09-29 Chinese
独立董事提名人声明
Board/Management Information Classification · 95% confidence The document is a public statement from the board nominating an independent director candidate for the company's board. It details the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically about director nomination. Therefore, the document fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed information about the nomination, not just an announcement or a brief notice.
2020-09-29 Chinese
职工代表大会决议
Board/Management Information Classification · 95% confidence The document is a resolution from the employee representative meeting regarding the election of a supervisory board member, including a detailed biography and compliance statements about the individual. It does not contain financial data, audit information, or regulatory filings related to financial performance. It is an announcement related to board/management changes, specifically the appointment of a supervisory board member. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on personnel changes, not a report or announcement of a report publication.
2020-09-29 Chinese
独立董事提名人声明
Board/Management Information Classification · 100% confidence The document is a public statement from the board of directors nominating an individual as an independent director candidate. It contains detailed declarations about the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There is no financial data, no discussion of financial results, no mention of annual or interim reports, earnings, or other financial filings. The content focuses exclusively on board/management matters, specifically the nomination of a board member. Therefore, this document fits the category of Board/Management Information (MANG). The document length is moderate and contains detailed statements, not just an announcement or a brief notice, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2020-09-29 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.